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Abstract
Aim: To determine the independent and combined associations of interleukin-1b
(IL-1b) and C-reactive protein (CRP) in gingival crevicular ﬂuid (GCF) on
periodontitis case status in the Australian population.
Materials and Methods: GCF was collected from 939 subjects selected from the
2004–2006 Australian National Survey of Adult Oral Health: 430 cases had examiner-
diagnosed periodontitis, and 509 controls did not. IL-1b and CRP in GCF were
detected by enzyme-linked immunosorbent assays. Odds ratios (OR) and 95%
conﬁdence intervals (CIs) were calculated in bivariate and stratiﬁed analysis and fully
adjusted ORs were estimated using multivariate logistic regression.
Results: Greater odds of having periodontitis was associated with higher amounts of
IL-1b (OR52.4, 95% CI51.7–3.4 for highest tertile of IL-1b relative to lowest
tertile) and CRP (OR51.9, 95% CI51.5–2.5 for detectable CRP relative to
undetectable CRP). In stratiﬁed analysis, there was no signiﬁcant interaction between
biomarkers (p50.68). In the multivariate analyses that controlled for conventional
periodontal risk factors, these relationships remained (IL-1b OR51.8, 95% CI5
1.1–2.6; CRP OR51.7, 95% CI51.3–2.3).
Conclusions: Elevated odds of clinical periodontitis was associated independently
with each biomarker. This suggests that people with elevated biomarkers indicative of
either local (IL-1b) or systemic (CRP) inﬂammation are more likely to suffer from
periodontal disease.
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Numerous studies have shown that bio-
markers of inﬂammatory response are
elevated in people with periodontitis
compared with healthy controls (Mogi
et al. 1999, Gamonal et al. 2000, Engeb-
retson et al. 2002, Bostanci et al. 2007,
Zhong et al. 2007). These biomarkers
include cytokines known to be produced
locally in periodontal tissues [e.g. inter-
leukin-1b (IL-1b)] as well as acute phase
reactants that predominantly are pro-
duced in tissues remote from the infection
[e.g. C-reactive protein (CRP), predomi-
nantly produced in liver]. Our own case–
control study conﬁrmed these ﬁndings in
samples of gingival crevicular ﬂuid
(GCF) collected from a representative
population-based sample of Australian
adults in which we measured IL-1b and
CRP (Fitzsimmons et al. 2009).
It is possible that inﬂammatory bio-
markers produced in tissues remote
from the periodontium become elevated
in response to periodontitis only as a
consequence of locally produced bio-
markers in the periodontium. If that
were so, then the association between
CRP and periodontitis would be depen-
dent upon IL-1b levels in the period-
ontium. However, if both CRP and
IL-1b are independently associated
with periodontitis, it would suggest the
relationship is more complex, and
potentially could offer insight into sepa-
rate mechanisms by which local and
systemic inﬂammatory responses are
related to the disease.
The relationship between inﬂamma-
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30 r 2009 University of Adelaidemost likely bidirectional. On the one
hand, bacterial infection in the perio-
dontal tissues stimulates a local immune
response involving the production and
release of several inﬂammatory media-
tors into the surrounding tissue. The role
of one such mediator, IL-1b, is well
known in periodontal disease progres-
sion (Lo et al. 1999, Graves & Cochran
2003) and as an indicator of active
inﬂammation. Produced locally at the
site of infection by a number of cells
involved in host defence against perio-
dontal pathogens including macro-
phages, neutrophils and gingival
ﬁbroblasts (Takahashi et al. 1995, Lo
et al. 1999, Steffen et al. 2000), IL-1b is
initially released to combat infection.
However, persistent infection leads to
the dysregulation of the immune system
and a cascade of events, initiated by IL-
1b, results in chronic inﬂammation of
the periodontal supporting tissues, cul-
minating in destruction of alveolar
bone mediated via IL-1b regulation of
osteoclasts (Graves & Cochran 2003).
These inﬂammatory processes in perio-
dontal tissues can trigger a more gen-
eralized systemic response in tissues
remote from the periodontium, such as
the liver.
Meanwhile, inﬂammatory processes
elsewhere in the body can contribute to
periodontitis. Some systemic diseases
(such as diabetes) that increase risk of
periodontitis also contribute to inﬂam-
matory responses in numerous tissues,
increasing systemic levels of each bio-
marker. Finally, there is speculation that
a common underlying hyper-inﬂamma-
tory phenotype might predispose peo-
ple, both to periodontitis and systemic
inﬂammation (Offenbacher & Beck
2005). These bidirectional effects mean
that elevated levels of inﬂammatory
biomarkers may signify both the causes
and consequences of periodontitis.
Given the likely bidirectional causal
pathways linking periodontitis and
inﬂammatory biomarkers, it is informa-
tive to examine these relationships using
periodontitis both as an explanatory
variable and separately as a dependent
variable. In our previous study, we used
periodontitis as an explanatory variable
to show that both IL-1b and CRP in
GCF were elevated in periodontitis
cases relative to non-cases (Fitzsim-
mons et al. 2009). However, we did
not attempt to determine if elevated
levels of CRP was associated with
periodontitis independently of the levels
of IL-1b.
Consequently, in the current analyses,
we focus on periodontitis as the depen-
dent variable with the primary aim to
determine the combined effects of each
biomarker on occurrence of clinical
periodontitis. Our hypothesis was that
each biomarker would contribute inde-
pendently to the odds of periodontitis,
and that their effects would be observa-
ble even after adjusting for conventional
risk factors for periodontitis. Such a
ﬁnding is consistent with the notion
that both local and systemic inﬂamma-
tory processes contribute to the risk of
having periodontitis.
If this hypothesis is supported, ﬁnd-
ings will build on existing evidence to
provide ‘‘proof-of-principle’’ support
for a potential etiological association
between both sources of inﬂammation
and periodontitis case status.
Materials and Methods
Study design and sampling
The current case–control study as pre-
viously described (Fitzsimmons et al.
2009) was nested within the National
Survey of Adult Oral Health (2004–
2006) (NSAOH) (Slade et al. 2007).
The University of Adelaide’s Human
Research Ethics Committee granted
approval for the National Survey. Dur-
ing the survey, 5505 people underwent
standardized oral epidemiological
examinations. All examined subjects
provided written informed consent
before the examination. Examinations
included measurements of periodontal
pocket depth (PD) and gingival reces-
sion on all teeth except third molars.
Three sites were assessed per tooth:
mesiobuccal, mid-buccal and distobuc-
cal. Clinical periodontal attachment
level was calculated as the sum of PD
and recession at each site during subse-
quent data management. Following
probing measurements, up to four perio-
dontal sites were selected at random
from among all measured periodontal
sites and used for collection of GCF
samples. An algorithm in the computer
program recording dental examination
data selected four periodontal sites at
random for collection of GCF samples.
Sites were selected from among all
periodontally measured sites within
each person’s mouth, yielding up to
two sites with probing depths of at least
4mm and the remaining sites with shal-
lower probing depths. GCF was col-
lected at four sites where recession and
probing depths were recorded. Where
all probing depth measurements were
o4mm, a simple random sampling
method was used to select all four sites.
Otherwise, a stratiﬁed random sampling
method was used to collect GCF from
up to two sites with probing depth 4mm,
and the remaining samples from sites
with probing depth o4mm.
Case deﬁnition
For this study, 939 examined survey
participants were selected using a
case–control study design. Cases were
people with two or more interproximal
sites with X4mm clinical attachment
loss and two or more interproximal sites
with PD of X5mm or more were
deﬁned as moderate or severe perio-
dontitis cases, while non-cases had less
extensive disease (Page & Eke 2007).
All examined NSAOH subjects who met
criteria as periodontal cases were
included in this study, while NSAOH
subjects who were non-cases were
sampled at random for this study to
select an approximately equivalent
number of non-cases for this study.
Non-cases from the NSAOH subjects
were selected at random using a random
number generator in SAS (SAS v.9.2,
SAS Institute, Cary, NC, USA), with
frequency matching within states/terri-
tories to achieve similar numbers of
cases and non-cases within each juris-
diction.
GCF collection and analysis
GCF was collected on two PerioPapert
strips (Oraﬂow Inc., Plainview, NY,
USA) per site as previously described
(Fitzsimmons et al. 2009). Brieﬂy, the
area was isolated from saliva with cot-
ton rolls and air dried before placing the
strip into the gingival crevice for 10s.
Paper strips were wrapped in foil before
shipping to the laboratory by mail where
they were frozen at  201C until pro-
cessed. GCF samples contaminated with
blood were processed but excluded from
analysis. GCF was eluted from each
individual PerioPapert strip as pre-
viously described (Fitzsimmons et al.
2009). GCF was eluted from Perio
Papert strips by a two-step centrifuga-
tion method. Each strip was eluted
separately by adding elution buffer
(1% bovine serum albumin solution,
R&D Systems, Minneapolis, MN,
USA) to the strip and incubating at
room temperature for 15min. before
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41C. This process was repeated before
combining eluted solution (ﬁnal volume
480ml) from each pair of strips before
storing at  201C until further analysis
by ELISA.
Levels of IL-1b and CRP in GCF
samples were determined using com-
mercially available ELISA kits [R&D
Systems (IL-1b) and Bender MedSys-
tems, Vienna, Austria (CRP)] following
the manufacturer’s guidelines. All stan-
dards and samples were assayed in
duplicate with biomarker concentrations
determined from standard curves gener-
ated with KC4 software (BioTek Instru-
ments, Winooski, VT, USA) using a
four-parameter logistic curve-ﬁt (IL-
1b) or linear regression (CRP) analysis.
Quantifying inﬂammatory biomarkers
The eluted IL-1b was multiplied by 0.48
to yield the amount in picograms at each
periodontal site, and its natural log was
computed to overcome the skewed nat-
ure of its distribution. For each person,
the mean value of log (amount) was
computed from among all sites assayed.
For the purpose of these analyses this
continuous variable was split into
approximately equal-sized tertiles
labelled ‘‘Low’’ (a mean of 1.0pg or
less of eluted IL-1b among assayed
sites), ‘‘Moderate’’ (a mean of
41.0pg to o3.3pg of eluted IL-1b)
and ‘‘High’’ (a mean of 3.3pg or more).
The lower limit of detection of the
CRP ELISA was 3pg/ml. The eluted
concentration of CRP fell below the
limit of detection for 58% of sites, so
the data were dichotomized to indicate
whether or not an amount of three or
more picograms per millilitre was
detected. A person-level variable was
computed to indicate whether or not the




Self-reported information about demo-
graphics, smoking history, self-rated
health and medical conditions were
asked either during a telephone inter-
view conducted before the examinations
or using a questionnaire completed on
the day of the examination. For each
medical condition, subjects were asked
‘‘Has a doctor or other health profes-
sional ever told you that you have . . .’’
(e.g. high blood pressure) and response
categories were ‘‘yes’’, ‘‘no’’ and
‘‘don’t know’’. The latter were coded
as missing and not used in this analysis.
Statistical analysis
To test the study hypothesis that IL-1b
and CRP were signiﬁcant independent
predictors of periodontitis, unconditional
logistic regression was used to compute
unadjusted odds ratios (OR) and corre-
sponding 95% conﬁdence intervals (95%
CIs) for these associations. ORs with
95% CIs that excluded 1.0 were judged
to be statistically signiﬁcant. Odds of
periodontitis were also examined for
selected subject socio-demographic
characteristics, cigarette smoking and
self-reported history of chronic condi-
tions, each of which is a recognized
periodontal risk indicator. The variable
hypothesized to modify the association
between CRP and periodontitis was IL-
1b. Consequently to test for potential
interaction, the association between CRP
and periodontitis was computed within
each stratum of IL-1b (low, moderate,
high). Crude ORs were compared with
these stratum-speciﬁc estimates using
the Breslow–Day test for homogeneity
of the odds. Finally, signiﬁcant predic-
tors were entered into a multivariate
logistic regression model to determine
whether, and to what extent, elevated
biomarkers remained signiﬁcant perio-
dontitis risk predictors after adjustment
for conventional risk indicators. To
investigate the sensitivity of these ﬁnd-
ings to the threshold used to deﬁne
periodontal case status, we repeated the
logistic regression analysis, excluding
subjects with moderate periodontitis, to
model the odds of having severe perio-
dontitis. All analyses were conducted
using SAS v.9.2 (SAS Institute).
Results
Of the 939 subjects selected from the
2004–2006 Australian National Survey
of Adult Oral Health, 430 were exam-
iner-diagnosed periodontitis cases,
and the remaining 509 non-cases. In
unadjusted analysis (Table 1) a dose–
response effect was evident of increas-
ing odds of periodontitis at elevated
levels of IL-1b. Likewise subjects with
detectable CRP were almost twice as
likely to be cases as those with unde-
tectable levels of this biomarker (OR
1.9, 95% CI 1.5–2.5). Conﬁrming pre-
vious ﬁndings, odds of periodontitis
were elevated at older age and among
males, non-Australian born subjects
born and former and current smokers
relative to their respective reference
groups. Also presenting as a signiﬁcant
risk indicator was history of chronic
health conditions. Elevated levels of
IL-1b were found in subjects with
detectable CRP and among males, the
non-Australian born and diabetics, rela-
tive to females, Australian-born subjects
and those with no diagnosis of diabetes.
Detectable levels of CRP were found in
signiﬁcantly higher proportions of the
aged and medically compromised than
in the young and healthy, although the
association with a history of high blood
cholesterol was non-signiﬁcant.
A non-signiﬁcant statistic for the
Breslow–Day test (p50.68) was evi-
dence for no effect modiﬁcation by IL-
1b levels in the association between
CRP and periodontitis (Table 2). Hence
no interaction term was entered into the
multivariable logistic regression model.
After adjustment for covariates
(Table 3), IL-1b and detectable CRP
remained signiﬁcantly associated with
periodontitis risk. Furthermore, odds of
periodontitis were elevated 80% for
each additional decade of life lived.
Males and non-Australian born subjects
remained about twice as likely to be a
case and current smokers had odds
elevated 3.6-fold (95% CI52.4–5.5)
relative to subjects who had never
smoked.
When the odds of severe periodontitis
was evaluated in a logistic regression
model that excluded cases of moderate
periodontitis, both mediators remained
statistically signiﬁcant. There was a
similar magnitude of effect for IL-1b
(for the mid-tertile of IL-1b,O R51.5,
95% CI50.7–2.9; for the high tertile of
IL-1b,O R 51.9, 95% CI51.0–3.6),
and a slightly stronger effect for CRP
(OR53.3, 95% CI52.0–5.5). The cov-
ariates listed in Table 3 also remained
statistically signiﬁcant, with similar or
greater ORs [e.g. up to 7.8 (95%
CI54.0–15.1) for current smoking].
Discussion
This study investigated the combined
effects of IL-1b and CRP in GCF on
presence of periodontitis in the Austra-
lian population. Increased odds of clin-
ical periodontitis was associated
independently with elevated biomarkers
that are indicative of local (IL-1b)o r
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tion a number of socio-demographic
variables were also associated with
increased odds of having periodontitis
and these included age, gender, smoking
status and country of birth. The ﬁndings
generally were similar when the more
stringent case deﬁnition of severe perio-
dontitis was used.
These ﬁndings are consistent with
those from a previous study, which
demonstrated that increased levels of
both IL-1b and CRP in GCF were
associated with age and country of birth
(Fitzsimmons et al. 2009). In addition to
these associations, the present study
determined that the levels of IL-1b and
the presence of CRP in GCF were sig-
niﬁcantly associated with a history of
diabetes or cardiovascular disease.
Furthermore, detectable levels of CRP
in GCF were also inﬂuenced by a his-
tory of high blood pressure and self-
reported poor health. These ﬁndings
strengthen the notion that periodontitis
involves inﬂammatory responses that
are associated with local and systemic
Table1. Inﬂuence of biomarker presence in GCF on odds of periodontitis




Low Medium High Detectable
IL-1b
Low-tertile 267 33.3 Ref.
§ – – – 25.1
Mid-tertile 322 46.3 1.7 (1.2–2.4) – – – 40.7
High-tertile 350 54.9 2.4 (1.7–3.4) – – – 55.4
p-value o0.01
CRP
Undetectable 547 39.1 Ref. 36.6 34.9 28.5 –
Detectable 392 55.1 1.9 (1.5–2.5) 17.1 33.4 49.5 –
p-value o0.01
Age (years)
15–44 306 22.6 Ref. 33.7 33.0 33.3 35.0
45–59 318 50.3 3.5 (2.5–4.9) 27.7 33.3 40.0 42.8
601 315 63.8 6.1 (4.3–8.6) 24.1 36.5 39.4 47.3
p-value 0.11 o0.01
Gender
Female 542 37.3 Ref. 30.3 36.2 33.6 42.4
Male 397 57.4 2.3 (1.7–3.0) 25.9 31.7 42.3 40.8
p-value 0.02 0.62
Country of birth
Australia 692 39.7 Ref. 30.9 35.7 33.4 41.8
Elsewhere 247 62.8 2.6 (1.9–3.4) 21.5 30.4 48.2 41.7
p-value o0.01 0.99
Smoking status
Never 457 37.9 Ref. 29.8 35.2 35.0 39.8
Former 307 50.5 1.7 (1.2–2.2) 28.0 34.9 37.1 44.3
Current 175 58.3 2.3 (1.6–3.3) 25.7 30.9 43.4 42.3
p-value 0.41 0.46
Diabetes history
No 879 44.7 Ref. 29.6 34.5 36.2 40.7
Yes 60 61.7 2.0 (1.2–3.4) 15.0 31.7 53.3 56.7
p-value 0.01 0.02
Cardiovascular disease history
No 898 44.9 Ref. 28.8 34.6 36.5 41.0
Yes 37 70.3 2.9 (1.4–5.9) 16.2 27.0 56.8 62.2
p-value 0.04 0.01
High blood pressure
No 674 42.0 Ref. 29.4 34.1 36.5 37.2
Yes 251 57.4 1.9 (1.4–2.5) 25.9 35.1 39.0 53.8
p-value 0.56 o0.01
High blood cholesterol
No 649 41.5 Ref. 28.8 36.1 35.1 40.8
Yes 266 57.1 1.9 (1.4–2.5) 25.9 31.2 42.9 42.9
p-value 0.09 0.57
General health
Good to excellent 825 44.0 Ref. 28.9 34.6 36.6 40.5
Poor to fair 114 58.7 1.8 (1.2–2.7) 25.4 32.5 42.1 50.9
p-value 0.51 0.03
n95% CI for OR.
wPercentage of people with low (o1.0 pg), medium (1.0 to o3.3pg) and high (X3.3 pg) amounts of IL-1b eluted from GCF.
zPercentage of people with detectable CRP in GCF.
§Reference group for OR.
CI, conﬁdence interval; OR, odds ratio; IL-1b, interleukin-1b; CRP, C-reactive protein; GCF, gingival crevicular ﬂuid.
GCF IL-1b, CRP and periodontitis 33
r 2009 University of Adelaidepatterns of inﬂammation and that sev-
eral systemic inﬂammatory conditions
may impact on periodontitis status pat-
terns. Although this study cannot iden-
tify the tissues in which each mediator
was produced, it seems likely that CRP
appears in GCF primarily as a serum
exudate following its production in the
liver. This is consistent with other stu-
dies demonstrating that oral pathogens
elicit an immune response with elevated
serum levels of CRP (Noack et al. 2001)
and IL-1b (Swoboda et al. 2008). While
it is well accepted that local biomarkers,
including various cytokines, and acute
phase proteins, are present in GCF
(Armitage 1996) the identiﬁcation and
measurement of CRP in GCF has been
relatively limited. Besides our previous
study (Fitzsimmons et al. 2009), there
are few other reports documenting the
presence of CRP in GCF (Sibraa et al.
1991, Tuter et al. 2007).
While increased levels of CRP in
GCF of periodontitis patients noted in
the present study are consistent with
previous reports of increased CRP in
serum from subjects with periodontitis
(Slade et al. 2000, Glurich et al. 2002,
Salzberg et al. 2006), we cannot com-
ment on the clinical signiﬁcance, if any,
of CRP thresholds used in this analysis.
Because there are no previous studies
showing clinical signiﬁcance of CRP
thresholds in GCF, we used the assay’s
detection threshold of 3pg/ml in eluted
GCF because it identiﬁed sufﬁcient
number of subjects to permit analysis
of associations. In a study of 67 subjects
(including 20 periodontal patients), Tuter
et al. (2007) analysed CRP in serum and
GCF, and found only a weak correlation
(Pearson’s r5  0.027, p40.05). Addi-
tional studies, preferably using longitudi-
nal designs that predicted risk of
periodontitis or other diseases, would be
needed to determine the clinical signiﬁ-
cance of this threshold.
The presence of CRP in GCF in the
current study also builds on the growing
body of evidence supporting a relation-
ship between periodontal disease and
systemic inﬂammatory conditions such
as diabetes, cardiovascular disease and
rheumatoid arthritis (Mercado et al.
2001, Persson et al. 2003, Perrino
2007). Associations between these con-
ditions and periodontitis are most likely
mediated by increased inﬂammatory
burden and the induction of acute phase
proteins such as CRP (D’Aiuto et al.
2004, Joshipura et al. 2004, Bizzarro et
al. 2007, Abou-Raya et al. 2008). Of
these associations, one of the most sig-
niﬁcant appears to be the increase in
CRP levels in people with periodontitis.
As demonstrated by us and others, this
has been implicated as a risk factor for
future cardiovascular events (Wu et al.
2000, D’Aiuto et al. 2004, Sun et al.
2009).
While there is accumulating evidence
implicating periodontitis as a risk factor
for other chronic conditions, the bidir-
ectional nature of these associations
needs to be recognized and analysed.
For example, in our study the odds of
having periodontitis was increased
approximately 2.5 by IL-1b and two
times by detectable CRP in unadjusted
analysis. Adjusted ORs were slightly
lower, with high levels of IL-1b and
detectable CRP increasing the odds of
having periodontitis by 1.8 and 1.7
times, respectively. These data are simi-
lar to those reported by Linden et al
(2008) where the adjusted OR of perio-
dontitis in a multivariable analysis was
increased by increased serum levels of
CRP to 2.49 (95% CI51.16–5.35). The
slight difference in values reported in
these two studies may be explained by
serum versus GCF detection of CRP and
varying differences in periodontitis case
deﬁnitions. Irrespective of these differ-
ences it is apparent that reasons for
increased levels of biomarkers in GCF
may be the result of periodontal disease
or they may be a consequence of other
systemic conditions such as cardiovas-
cular disease diabetes, or rheumatoid
arthritis. This important distinction
remains to be elucidated (Grossi &
Genco 1998, Mealey 2006).
An important ﬁnding of the present
study was that although the stratiﬁed
analysis of the presence of IL-1b
together with CRP showed a trend
towards an increased risk of having
Table2. Odds ratios (OR) and corresponding 95% conﬁdence intervals (CI) between C-reactive










Low Undetectable 200 31.5 Ref.
n
Detectable 67 38.8 1.4 (0.8–2.5)
Medium Undetectable 191 41.2 Ref.
Detectable 131 53.4 1.6 (1.0–2.5)
High Undetectable 156 46.1 Ref.
Detectable 194 61.9 1.9 (1.2–2.9)
nReference group for OR.
w
2 (2df)50.68, p50.77 from Breslow–Day test of homogeneity of odds ratios among three tertiles
of IL-1b.
Table3. Multivariate logistic regression model predicting odds of periodontitis (n5938)





















nReference group for odds ratio.
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interaction between the two biomarkers.
The notion that cytokines and immune
regulators inﬂuence the risk of systemic
disease is not a new concept. The com-
bination of IL-6 and IL-1b indepen-
dently increases the risk of diabetes by
approximately three times (Spranger
et al. 2003). Increased CRP and IL-6
are also shown to increases the risk of
diabetes type 2 by 2.3 and 4.2 times,
respectively (Pradhan et al. 2001).
Given that IL-1b and CRP are part of
a much larger network of cytokines and
inﬂammatory mediators, analysis of the
combination of these two biomarkers in
isolation may partially explain these
results. Other cytokines, particularly
tumour necrosis factor-a and IL-6 are
two key regulators of IL-1b and CRP,
respectively. In addition, the induction
of CRP expression by IL-6 is synergistic
with IL-1b (Ganapathi et al. 1991).
Well-documented evidence of increased
levels of IL-6 in GCF from subjects with
periodontitis (Mogi et al. 1999, Sun
et al. 2009) may partially explain the
present observations of CRP in GCF.
Aside from the limitations of a case–
control study design, which preclude us
from determining whether inﬂammatory
mediators are a cause or consequence of
periodontitis (or both), the principal
limitations of this study arise from sim-
pliﬁcation of measurements that are
needed for population studies. Speciﬁ-
cally, we assessed GCF at only four sites
per subject, and clinical periodontal
measurements were made at only three
sites per tooth, not six. In addition, we
were reliant on self-reported informa-
tion about medical history and health
behaviours (e.g. smoking) that are
known to inﬂuence inﬂammation. None-
theless, the selection of cases and con-
trols from a larger population survey
helps to minimize biases association
with sampling from patient groups,
and it means that the ﬁndings can be
generalized to the Australian adult
population.
In summary, the odds of individuals
having periodontitis were increased by
the presence of biomarkers traditionally
indicative of local (IL-1b) and systemic
inﬂammation (CRP). These ﬁndings
support our hypothesis that people with
evidence of local or systemic inﬂamma-
tion are more likely to suffer from
periodontal disease. Importantly, the
effects of IL-1b and CRP were noted
to be independent and statistically sig-
niﬁcant in a multivariable model that
adjusted for conventional risk indica-
tors. Hence we conclude that there was
no interaction between IL-1b and CRP.
Such independence adds further to our
understanding that a chronic disease
such as periodontitis may be under
bidirectional inﬂuences. For example, a
local inﬂammatory response could be
expected to result in a local increase in
production of inﬂammatory cytokines
such as IL-1b. However, localized
inﬂammation can also result in a more
generalized systemic inﬂammatory
response in distant organs, including
the liver. In addition, individuals who
manifest a hyper-inﬂammatory pheno-
type are predisposed to tissue destruc-
tion in response to local periodontal
infection. Thus local and systemic fac-
tors may act both independently and
synergistically in a complex disease
such as periodontitis. In order to address
these issues a prospective cohort study
is required. Overall, these data support
our original hypothesis that people with
evidence of local or systemic inﬂamma-
tory biomarkers in GCF are more likely
to suffer from periodontal disease.
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Scientiﬁc rationale for study:
Increasing evidence suggests that
periodontal disease consists of local
and systemic inﬂammatory compo-
nents. Most research investigating
systemic biomarkers has focussed
on serum concentrations. We exam-
ined the relationship between the
presence of local (IL-1b) and sys-
temic (CRP) biomarkers in GCF and
risk of periodontitis.
Principal ﬁndings: Odds of having
periodontitis were increased by pre-
sence of local and systemic biomar-
kers. High levels of IL-1b were
positively associated with a history
of diabetes, cardiovascular disease
and high blood cholesterol. Detect-
able CRP was positively associated
with a history of diabetes, cardiovas-
cular disease and hypertension.
Practical implications: Biomarkers
that indicate systemic inﬂammation
observed in periodontitis may con-
tribute not only to periodontal dis-
ease pathogenesis but also the
inﬂammatory load of other systemic
conditions such as diabetes and car-
diovascular disease.
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